## **Core Concept**
Trastuzumab is a monoclonal antibody that targets the **HER2/neu receptor**, which is overexpressed in certain types of cancer, most notably breast cancer. It works by binding to the HER2 protein, preventing receptor dimerization and subsequent signaling that promotes cell proliferation.

## **Why the Correct Answer is Right**
Trastuzumab's mechanism involves **inhibiting the proliferation of cells that overexpress HER2**. This is specifically beneficial in breast cancers that have been identified as HER2-positive. The drug's efficacy in reducing tumor growth and improving survival rates in HER2-positive breast cancer patients underscores its targeted therapy approach.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not provided, so cannot assess.
- **Option B:** Not provided, so cannot assess.
- **Option C:** Not provided, so cannot assess.
- **Option D:** Not provided, so cannot assess.

## **Clinical Pearl / High-Yield Fact**
A key point to remember about trastuzumab is that it can cause **cardiotoxicity**, particularly when used in conjunction with anthracyclines. Monitoring cardiac function is crucial during treatment. Additionally, trastuzumab is used in the treatment of **HER2-positive metastatic breast cancer** and **early-stage HER2-positive breast cancer**.

## **Correct Answer:** D. Not provided